Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Regranion LLC
Profile last edited on: 6/8/21      CAGE: 5KJ68      UEI: MC1LNCYZJCK9

Business Identifier: Inflammatory skin diseases
Year Founded
2009
First Award
2017
Latest Award
2020
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

59 Krier Lane
Mount Pleasant, SC 29464
   (843) 388-3276
   info@regranion.com
   www.regranion.com
Location: Single
Congr. District: 01
County: Charleston

Public Profile

Regranion, LLC is a clinical-stage pharmaceutical company delivering breakthrough solutions for inflammatory skin diseases by targeting a conserved pathway that contributes to hyperinflammation.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$252,132
Phase II Dollars
$1,225,570
Total Awarded
$1,477,702

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2020 1 NIH $252,131
Project Title: Novel Small Molecule HSP90 Inhibitor for the Management of Atopic Dermatitis
2018 2 NIH $1,225,571
Project Title: A Novel Topical HSP90 Inhibitor (CTXT-102) in the Treatment of Mild to Moderate Plaque Psoriasis

Key People / Management

  Gautam Ghatnekar -- Chair

  Christina Grek -- Director of Translational Research

Company News

There are no news available.